Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$39.69

1.14 (2.96%)

16:21
11/06/18
11/06
16:21
11/06/18
16:21

Global Blood Therapeutics reports Q3 EPS (83c), consensus (86c)

Cash, cash equivalents and marketable securities totaled $482.1 million at September 30, 2018, compared with $329.4 million at December 31, 2017."Voxelotor has the potential to be a transformative treatment for the sickle cell community. We remain in active discussions with the U.S. Food and Drug Administration regarding the potential for accelerated approval of voxelotor. We continue to believe that voxelotor meets the standard for accelerated approval based on the statistically significant and clinically meaningful increase in hemoglobin and reduction in hemolysis," said Ted W. Love, M.D., president and chief executive officer of GBT. "Our guidance remains that we expect to provide a regulatory update by the end of this year. Additionally, we look forward to reporting an expanded data set from Part A of the HOPE Study and data from the 1500 mg cohort of the HOPE-KIDS 1 Study at the American Society of Hematology Annual Meeting later this year."

  • 01

    Dec

  • 03

    Dec

GBT Global Blood Therapeutics
$39.69

1.14 (2.96%)

10/15/18
PIPR
10/15/18
NO CHANGE
PIPR
Piper lists names to own in Biopharma after recent selloff
Piper Jaffray's biopharma analyst team highlighted names to own in the Biopharma sector following the recent selloff of the broader market. The firm's ideas include: Adamas Pharmaceuticals (ADMS), Agios Pharmaceuticals (AGIO), Agios Pharmaceuticals (ALNY), Alexion (ALXN), Bluebird Bio (BLUE), BioMarin (BMRN), CymaBay (CBAY), Crispr Therapeutics (CRSP), Global Blood Therapeutics (GBT), Horizon Pharma (HZNP), Jazz Pharmaceuticals (JAZZ), Ocular Therapeutix (OCUL), Rigel Pharmaceuticals (RIGL) and Xencor (XNCR).
10/18/18
PIPR
10/18/18
NO CHANGE
PIPR
Piper Jaffray says FDA workshop 'net positive' for Global Blood Therapeutics
Piper Jaffray analyst Danielle Brill viewed the discussion at the FDA-ASH SCD clinical endpoints workshop as a "net positive" for Global Blood Therapeutics, saying it "provided hints of support" for the accelerated approval of voxelotor. Brill maintained an Overweight rating and $80 price target on Global Blood Therapeutics shares.
10/19/18
OPCO
10/19/18
NO CHANGE
Target $74
OPCO
Outperform
FDA may consider accelerated voxelotor approval after workshop, says Oppenheimer
Oppenheimer analyst Mark Breidenbach reiterated an Outperform rating and $74 price target on Global Blood Therapeutics after attending a joint FDA-ASH workshop on clinical endpoints for sickle cell disease. In a research note to investors, the analyst says he believes the workshop was supportive of endpoint flexibility and could spur the FDA to consider accelerated approval of voxelotor based on reduction of hemolytic anemia.
11/01/18
PIPR
11/01/18
NO CHANGE
PIPR
Overweight
Global Blood's adolescent TCD data encouraging, says Piper Jaffray
Piper Jaffray analyst Danielle Brill noted that Global Blood Therapeutics has four abstract presentations at this year's ASH meeting, including first TCD data from its Phase 2a trial enrolling adolescents aged 12-17 with SCD and evaluating both 900mg and 1500mg voxelotor doses. Although the abstract only highlights improvement in a single subject, she is encouraged by the finding, Brill tells investors. Of the "most interest" will be detailed results from Part A of the Phase 3 HOPE trial, but on that front it "looks like all the meaningful updates" will be presented in December, Brill added. She keeps an Overweight rating on Global Blood shares.

TODAY'S FREE FLY STORIES

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:22
02/22/19
02/22
15:22
02/22/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the holiday-shortened…

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$55.68

0.14 (0.25%)

, XLE

Energy Select Sector SPDR

$65.66

0.1 (0.15%)

15:22
02/22/19
02/22
15:22
02/22/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

At time of writing the…

XLB

S&P Select Materials SPDR

$55.68

0.14 (0.25%)

XLE

Energy Select Sector SPDR

$65.66

0.1 (0.15%)

XLF

Financial Select Sector

$26.43

-0.085 (-0.32%)

XLI

Industrial Select Sector SPDR

$75.89

0.19 (0.25%)

XLY

Consumer Discretionary Sector SPDR

$110.81

0.31 (0.28%)

XLV

Health Care Select Sector SPDR

$92.29

0.59 (0.64%)

XLK

Technology Select Sector SPDR

$70.39

0.64 (0.92%)

SPY

SPDR S&P 500 ETF Trust

$278.35

0.92 (0.33%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:21
02/22/19
02/22
15:21
02/22/19
15:21
Conference/Events
House Appropriations Committee to hold a hearing »

The Subcommittee on…

RF

Regions Financial

$16.16

-0.085 (-0.52%)

15:20
02/22/19
02/22
15:20
02/22/19
15:20
Options
Call spreads in Regions Financial as bullish positions are adjusted »

Call spreads in Regions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
02/22/19
02/22
15:17
02/22/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
02/22/19
02/22
15:16
02/22/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$19.57

0.16 (0.82%)

15:15
02/22/19
02/22
15:15
02/22/19
15:15
Options
Under Armour put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

15:15
02/22/19
02/22
15:15
02/22/19
15:15
General news
Treasury Action: Treasuries have been underpinned all day »

Treasury Action:…

ABBV

AbbVie

$79.47

0.71 (0.90%)

, AZN

AstraZeneca

$40.78

0.345 (0.85%)

15:14
02/22/19
02/22
15:14
02/22/19
15:14
Conference/Events
Senate Finance Committee to hold a hearing »

The Committee holds a…

ABBV

AbbVie

$79.47

0.71 (0.90%)

AZN

AstraZeneca

$40.78

0.345 (0.85%)

BMY

Bristol-Myers

$50.75

0.6 (1.20%)

JNJ

Johnson & Johnson

$136.22

0.82 (0.61%)

MRK

Merck

$80.39

0.57 (0.71%)

PFE

Pfizer

$42.91

0.77 (1.83%)

SNY

Sanofi

$41.10

-0.23 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

MGA

Magna

$54.61

2.015 (3.83%)

15:04
02/22/19
02/22
15:04
02/22/19
15:04
Downgrade
Magna rating change  »

Magna downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

LTRPA

Liberty TripAdvisor

$16.20

0.31 (1.95%)

15:04
02/22/19
02/22
15:04
02/22/19
15:04
Options
Liberty TripAdvisor options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.32

0.89 (0.32%)

14:59
02/22/19
02/22
14:59
02/22/19
14:59
Periodicals
U.S. Treasury Secretary says U.S, China reach pact on currency issues, CNBC says »

Steven Mnuchin, U.S.…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.32

0.89 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
02/22/19
02/22
14:55
02/22/19
14:55
General news
Fed's Bullard doesn't want to be shrinking the balance sheet and cutting rates »

Fed's Bullard…

ALXN

Alexion

$128.46

0.9 (0.71%)

14:52
02/22/19
02/22
14:52
02/22/19
14:52
Hot Stocks
Alexion says FDA grants priority review and accepts sBLA of Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

14:50
02/22/19
02/22
14:50
02/22/19
14:50
Conference/Events
Senate Energy & Natural Resources Committee to hold a hearing »

The Committee holds a…

JMEI

Jumei

$2.68

0.19 (7.63%)

14:49
02/22/19
02/22
14:49
02/22/19
14:49
Options
Jumei options imply 7.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGR

Avangrid

$48.84

-0.06 (-0.12%)

14:42
02/22/19
02/22
14:42
02/22/19
14:42
Conference/Events
Avangrid to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 04

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.77

1.34 (0.48%)

14:42
02/22/19
02/22
14:42
02/22/19
14:42
Periodicals
Xi tells Trump both sides will redouble efforts to come to trade pact, CNBC says »

In a letter to U.S.…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.77

1.34 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:40
02/22/19
02/22
14:40
02/22/19
14:40
General news
Fed's Quarles confirmed the FOMC's decision to maintain an "ample" reserve balance »

Fed's Quarles…

PDVW

pdvWireless

$46.00

5.105 (12.48%)

14:30
02/22/19
02/22
14:30
02/22/19
14:30
Hot Stocks
pdvWireless move higher attributed to FCC proposed rulemaking notice »

Shares of pdvWireless are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
02/22/19
02/22
14:25
02/22/19
14:25
General news
Action Economics Survey results: »

Action Economics Survey…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
02/22/19
02/22
14:17
02/22/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
02/22/19
02/22
14:16
02/22/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUFG

Mitsubishi UFJ

$5.27

-0.02 (-0.38%)

14:15
02/22/19
02/22
14:15
02/22/19
14:15
Hot Stocks
OCC issues cease and desist order against MUFG Bank over BSA violation »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

XOG

Extraction Oil & Gas

$4.64

0.83 (21.78%)

14:13
02/22/19
02/22
14:13
02/22/19
14:13
Recommendations
Extraction Oil & Gas analyst commentary  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.